Octreotide therapy in two children with intractable postoperative chylothorax.
Postoperative chylothorax is sometimes difficult to be managed either by conventional therapies or by surgery. Herein, we report the experience of octreotide therapy for intractable postoperative chylothorax in two children (one was severe tetralogy of Fallot received Blalock-Taussing shunt, and the other was a single ventricle received bi-directional Glenn shunt) and review the literature on octreotide efficacy.
Hung
Wen-Pin
WP
Wang
Jieh-Neng
JN
Chang
Hok-Keong
HK
Wu
Jing-Ming
JM
D002916:Chylothorax / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015282:Octreotide / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy*; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
D013004:Somatostatin; D015282:Octreotide